Live Price
Live Volume
Outlook Therapeutics Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
| Open | $0.5449 |
|---|---|
| Close | $0.5250 |
| Low | $0.5200 |
| Low Change | -0.0249 (-4.57%) |
| High | $0.5500 |
| High Change | +0.0051 (+0.94%) |
| Range | $0.0300 |
| Volume | 187.696K |
| Dollar Volume | $98.54K |
Regular Trading Hours Yesterday
| Open | $0.5300 |
|---|---|
| Close | $0.5415 |
| Low | $0.5212 |
| Low Change | -0.0088 (-1.66%) |
| High | $0.5469 |
| High Change | +0.0169 (+3.19%) |
| Range | $0.0257 |
| Volume | 1.829M |
| Dollar Volume | $990.62K |
Premarket Yesterday
| Open | $0.5740 |
|---|---|
| Close | $0.5263 |
| Low | $0.5263 |
| Low Change | -0.0477 (-8.31%) |
| High | $0.5740 |
| High Change | +0.0000 (+0.00%) |
| Range | $0.0477 |
| Volume | 120.648K |
| Dollar Volume | $63.50K |
Outlook Therapeutics News
3 months agoinvesting.comWhy is Outlook Therapeutics stock plunging today?
- 3 months agoinvesting.com
Why is Outlook Therapeutics stock surging today?
- 5 months agoinvesting.com
Outlook Therapeutics stock surges on FDA BLA resubmission
- 5 months agoinvesting.com
Outlook Therapeutics stock surges after winning FDA appeal
- 10 months agoinvesting.com
Baidu, ASML, furniture stocks rise; Outlook Therapeutics sinks
- 10 months agoinvesting.com
Outlook Therapeutics stock plunges after FDA rejects wet AMD drug application
Outlook Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Outlook Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $0.5338 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.5267 |
| 20 Day Moving Average (SMA20) | $0.5503 |
| 50 Day Moving Average (SMA50) | $0.6097 |
| 100 Day Moving Average (SMA100) | $0.9455 |
| 200 Day Moving Average (SMA200) | $0.6643 |
Outlook Therapeutics Statistics
| Average Volume (30 Days) | 4.69M |
|---|---|
| P/E Ratio (Current) | -3.00 |
| EPS (Current) | -$0.20 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$56.15M |
| Cash Ratio | 0.39 |
| Current Ratio | 0.81 |
| Quick Ratio | 0.63 |
| Debt to Equity | -1.75 |
| Enterprise Value | $153.05M |
| EV to EBITDA | -4.00 |
| EV to Sales | -142.81 |
| Price to Book | -14.06 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | -136.30 |
| Return on Assets | -1.83% |
| Return on Equity | 4.60% |
Outlook Therapeutics Stock Splits
There have been 2 stock splits for Outlook Therapeutics (OTLK). The last reverse stock split occured on March 14, 2024 and reduced the outstanding shares at a ratio of 20:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 14, 2024 | Reverse | 20:1 |
| Mar 18, 2019 | Reverse | 8:1 |
Outlook Therapeutics Dividends
There have been no dividends for Outlook Therapeutics (OTLK).